Lycia Therapeutics logo

Lycia Therapeutics

South San Francisco, CA

We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

lyciatx.com

Company Details

Founded

2019

Employees

Between 20 - 50 employees

Raised

$226,600,000

Headquarters Location

South San Francisco, CA

Public

No

Acquired

No

CEO

Aetna Wun TrombleyAetna Wun Trombley

Founders

Carolyn Bertozzi
Carolyn Bertozzi

Company Collections

These are collections Lycia Therapeutics is a part of. Click on the collection name to view similar companies.

Lycia Therapeutics' Industries

Lycia Therapeutics' Tech Stack

Company Collections For Lycia Therapeutics

Lycia Therapeutics Headquarters Location

400 E Jamie Ct suite 200, South San Francisco, CA 94080

Total Amount Raised: $226,600,000

Lycia Therapeutics Funding Rounds

  • Series C

    $106,600,000

    Series C Investors

    Venrock Healthcare Capital Partners
    Henderson Global Investors
    Cowen
    Eli Lilly and Company
    RTW Investments
    Franklin Resources, Inc.
    Marshall Wace
    Invus
    Alexandria Venture Investments
    Redmile Group
    Blue Owl

  • Series B

    $70,000,000

    Series B Investors

    Redmile Group
    Cowen
    Alexandria Venture Investments
    Versant Ventures
    Invus
    Eli Lilly and Company
    RTW Investments

  • Series A

    $50,000,000

    Series A Investors

    Versant Ventures
Funding info provided by Diffbot.

Lycia Therapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Lycia Therapeutics.

Recent reviews